Forian’s (FORA) “Buy” Rating Reiterated at Roth Mkm

Forian (NASDAQ:FORA)‘s stock had its “buy” rating reaffirmed by analysts at Roth Mkm in a note issued to investors on Thursday,Benzinga reports. They currently have a $5.00 price objective on the stock. Roth Mkm’s price target would suggest a potential upside of 150.00% from the stock’s previous close.

Forian Price Performance

Shares of NASDAQ:FORA opened at $2.00 on Thursday. The company’s fifty day moving average price is $2.13 and its 200-day moving average price is $2.43. The firm has a market capitalization of $62.22 million, a price-to-earnings ratio of -22.22 and a beta of 1.09. Forian has a one year low of $1.99 and a one year high of $4.15.

Forian (NASDAQ:FORA) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.06). The business had revenue of $4.78 million during the quarter, compared to analyst estimates of $5.26 million. During the same quarter last year, the firm earned ($0.03) EPS.

Hedge Funds Weigh In On Forian

A number of large investors have recently modified their holdings of FORA. Caprock Group LLC purchased a new stake in Forian in the second quarter worth approximately $230,000. Canton Hathaway LLC raised its stake in shares of Forian by 2.3% during the third quarter. Canton Hathaway LLC now owns 269,650 shares of the company’s stock worth $582,000 after acquiring an additional 6,125 shares in the last quarter. Finally, Elser Financial Planning Inc bought a new stake in shares of Forian in the 2nd quarter worth approximately $1,885,000. 19.25% of the stock is owned by hedge funds and other institutional investors.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.